| 前收市價 | 141.10 |
| 開市 | 141.96 |
| 買盤 | 136.80 x 200 |
| 賣出價 | 137.53 x 100 |
| 今日波幅 | 135.16 - 142.36 |
| 52 週波幅 | 83.75 - 161.00 |
| 成交量 | |
| 平均成交量 | 338,479 |
| 市值 | 7.767B |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -9.51 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 0.29 |
ZacksWhy Earnings Season Could Be Great for Ascendis Pharma (ASND)
Ascendis Pharma (ASND) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Investor's Business DailyBiotech With 520% Sales Growth Nears Next Buy Point
This biotech growth stock is climbing its way up a base on its way to a buy point. The company's sales are expected to continue to soar.
Investor's Business DailyTwo Health Care Stocks Outperform S&P 500, Offer Entries
Procept BioRobotics and Ascendis Pharma may not show profits but the stocks have outperformed the S&P 500 in 2024. Shares are near buy points.
